Physician profile
Scott William Jones
NPI 1346290897
$1,021.69
in general payments reported to CMS, 2019-2025
17 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $27.52 · 2022: $36.91 · 2023: $118 · 2024: $211 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $202.68 | 2023-2025 | Cardiomems, Freestyle Libre 3 |
| Amgen INC. | $199.93 | 2019-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $175.59 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $105.78 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.04 | 2023-2024 | Jardiance |
| Boston Scientific Corporation | $65.41 | 2023-2025 | Watchman Flx |
| Heartflow, INC. | $33.04 | 2025 | |
| Janssen Pharmaceuticals, INC | $27.20 | 2019 | |
| Kestra Medical Technology Services, INC. | $23.54 | 2024 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $22.53 | 2023 | |
| Pfizer INC. | $19.19 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $19.15 | 2022 | |
| Esperion Therapeutics, INC. | $14.97 | 2024 | Nexletol |
| Edwards Lifesciences Corporation | $13.50 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.56 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $10.32 | 2025 | Barostim Neo System |
| Cardiovascular Systems INC. | $8.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.